CEA Pharm IVS: Financial statements 2020
CVR: 38463721
Source: annual report 2020, Danish Business Authority
01/10/2019 – 30/09/2020
CEA Pharm IVS (CVR 38463721) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 3,305 and a net result of DKK -3,305 compared with DKK -3,125 the year before. That is an increase of 5.8% compared with the year before. Equity in the 2020 report amounted to DKK -7,055.
- Gross Profit
- DKK 3,305
- Profit/Loss
- DKK -3,305
- Equity
- DKK -7,055
- Total Assets
- DKK 5,000
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 3 t. | -3 t. | -7 t. | 0 |
| 2019 | - | 3 t. | -3 t. | -4 t. | - |
| 2018 | - | 3 t. | -3 t. | -625 | - |
Official annual report
How creditworthy is CEA Pharm IVS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
CEA Pharm IVS has published its annual report for 2019. Gross profit came to DKK 3,125, and the net result was DKK -3,125.
About CEA Pharm IVS
CEA Pharm IVS was a Danish company of the type Iværksætterselskab based in Charlottenlund, founded in 2017. The company has been dissolved on 17 June 2021. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named CEA Sport IVS. According to the 2020 annual report, the company had an average of 0 employees. In 2020, the company reported a gross profit of DKK 3,305 and a net result of DKK -3,305 compared with DKK -3,125 the year before. Equity in the 2020 report amounted to DKK -7,055.